Advertisement
NKGen Biotech Inc. Common... (NKGN)
NASDAQ: NKGN
· Real-Time Price · USD
0.17
0.02 (13.33%)
At close: Apr 29, 2025, 2:52 PM
Company Description
Graf Acquisition Corp.
IV does not have significant operations.
It focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or other business combination with one or more businesses.
Graf Acquisition Corp.
IV was incorporated in 2021 and is based in The Woodlands, Texas.
NKGen Biotech Inc. Common Stock
| Country | United States |
| IPO Date | Oct 2, 2023 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 63 |
| CEO | Dr. Paul Y. Song M.D. |
Advertisement
Contact Details
Address: 1790 Hughes Landing Boulevard The Woodlands, Texas United States | |
| Website | https://www.grafacq.com |
Stock Details
| Ticker Symbol | NKGN |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | n/a |
| CUSIP Number | 65488A101 |
| ISIN Number | US65488A1016 |
| Employer ID | - |
| SIC Code | n/a |
Key Executives
| Name | Position |
|---|---|
| Dr. Paul Y. Song M.D. | Chief Executive Officer & Chairman |
| James A. Graf | Interim Chief Financial Officer |
| Denise A. Chua CLS, MBA, MT (ASCP) | SVice President of Corporate Affairs |
| Dr. Yong Man Kim Ph.D. | Chief Scientific Officer |
| Irene Chang | SVice President, HR & Corporate Culture |
| Ryan Park C.F.A. | EVice President of FP&A, Corporate Planning & Strategy |
| Yoonmi Kang | SVice President of Technical Ops & Development |